Novel antipsychotic medications are increasingly being used as first-line agents in treating schizophrenia as well as other psychotic disorders.1 Although olanzapine and quetiapine fumarate have not been reported to cause notable neutropenia, and blood monitoring is not required as is with clozapine, the following is a report of a case of persistent neutropenia in a patient treated with both agents.
Jackson RS. Continuing Treatment With Novel Antipsychotic Drugs Despite Leukopenia or Thrombocytopenia. Arch Gen Psychiatry. 2001;58(7):706-707. doi:10.1001/archpsyc.58.7.706